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Summary
Background: The performance of the Cockcroft-Gault 
(CG) equation, the Modification of Diet in Renal Dis-
ease (MDRD) formula, and the Chronic Kidney Disease 
Epidemiology Collaboration equation (CKD-EPI) was 
evaluated in body mass index (BMI) categories. Ma-
terial and Methods: In this retrospective cohort study 
in diabetic patients, creatinine clearance was meas-
ured by collecting 24-hour urines. Renal function was 
estimated using the CG, MDRD, and CKD-EPI. The per-
formance of the equations was evaluated using corre-
lation, Krippendorff’s coefficient, bias, precision, and 
accuracy. Results: The bias of the MDRD and CKD-EPI 
increased from –13.9 ml/min/1.73 m2 and –14.0 ml/
min/1.73 m2 (BMI < 25 kg/m2), respectively, to –31.7 ml/
min/1.73 m2 and –29.6 ml/min/1.73 m2 (BMI > 30 kg/m2), 
respectively. Bias of the CG decreased from –13.4 ml/min 
(BMI < 25 kg/m2) to –3.2 ml/min (BMI > 30 kg/m2). With an 
accepted 30% dispersion, CG had the largest accuracy in 
the overweight and obese group (76.9 and 76.8%, respec-
tively). The MDRD and CKD-EPI had an accuracy of 45.8 
and 34.0% (overweight group), respectively,and 51.9 and 
37.3% (obese group), respectively. Conclusions: All renal 
function prediction equations are biased when used in 
overweight or obese diabetic populations with preserved 
renal function. The CG provides the best estimate of kid-
ney function. The limitations of renal function prediction 
equations should be kept in mind when making clinical 
decisions.
Introduction
Because of the worldwide increasing prevalence of obesity 
and its associated problems such as diabetes mellitus (DM) 
and hypertension [1–3], the number of patients with complica-
tions such as renal function loss will also increase. Diagnosing 
renal dysfunction at an early stage is advocated, since early 
changes in lifestyle and pharmacological interventions can 
prevent or slow down further progression of renal damage 
[4–6]. To facilitate early recognition of chronic kidney disease 
(CKD), the Kidney Disease Outcome Quality Initiative 
(KDOQI) guidelines were introduced [7]. These guidelines 
classify CKD based on structural abnormalities, persisting 
 albuminuria and/or hematuria of glomerular origin and an 
 estimated glomerular filtration rate (eGFR) [8, 9]. Increased 
urinary excretion of albumin is an early and sensitive marker 
of CKD due to DM and hypertension. Numerous studies have 
shown a strong independent association between the level of 
urinary protein excretion and the risk of cardiovascular mor-
tality in populations with DM [8, 10, 11]. Besides albuminuria, 
eGFR remains the cornerstone for assessment and staging of 
CKD. Since the use of serum creatinine alone as a measure 
for renal function is too inaccurate, and inulin, radioactive 
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tracer elements, or 24-hour urine collections are either expen-
sive or cumbersome in daily practice, different formulae have 
been developed in the past decades to estimate the GFR or 
creatinine clearance (Crcl). 
There is considerable debate regarding the indiscriminate 
use and interchangeable results of the 4-variable Modification 
of Diet in Renal Disease (MDRD) equation [12], the Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation [13], and the Cockcroft-Gault (CG) equation [14] in 
overweight and obese patients [15–20]. The MDRD, based on 
GFR measurements using 125I-iothalamate, was developed in 
a relatively young population (subjects < 70 years of age) with 
known renal disease (mean GFR 39.8 ml/min/1.73 m2) and 
overt proteinuria (> 1 g/day urinary protein loss). The body 
weight of these subjects was ≥ 80% and ≤ 160% of their stan-
dard body weight. The MDRD is considered to be reliable in 
subjects with a GFR ≤ 60 ml/min/1.73 m2, and is indexed for a 
body surface area (BSA) of 1.73 m2 (which approximates the 
BSA of a non-overweight average-sized person) [12]. The 
CKD-EPI was developed in an attempt to get a better esti-
mate of GFR in values exceeding 60 ml/min/1.73 m2. It was 
developed in a population with a mean GFR of 68 ml/min/1.73 
m2 (indexed for BSA) and a mean BMI of 28 kg/m2 [13]. The 
CG is an equation to estimate the Crcl that was developed in 
a cohort of largely non-obese male subjects with a wide age 
range, a weight within the 10% range of fat-free body mass, 
and normal renal function [14]. Therefore, a CG estimate is 
considered to be especially reliable in Crcl levels > 60 ml/min. 
Unlike the MDRD and the CKD-EPI, body weight is in-
cluded as a variable because it is a crude estimate of muscle 
mass and therefore also of creatinine ‘production’. Since ex-
cess body weight in an overweight and obese population 
 usually comprises adipose tissue and not muscle mass, this 
formula is thought to have considerable limitations in this 
 patient category.
Theoretically, the CG will virtually always provide higher 
results than the MDRD, since the CG equation not only 
 represents glomerular function but also tubular function. Fur-
thermore, most adults will have a larger BSA than the stan-
dard BSA of 1.73 m2 which is used in the MDRD and CKD-
EPI. This means that these differences may lead to misunder-
standings and incorrect interpretation of results. Therefore, 
we aimed to investigate the influence of (over)weight on the 
performance of the MDRD and CKD-EPI equations versus 
the CG equation in diabetic patients, and to analyze the effect 
on the (mis)classification of CKD. 
Material and Methods
Study Population
The data for this retrospective, observational, cross-sectional study were 
collected from May 2005 until December 2006 at the outpatient clinic of 
the Maxima Medical Center in Eindhoven, the Netherlands. During that 
period, 1,095 24-hour Crcl of adult patients with DM were collected. An 
anonymous database was created with data abstracted from the ‘Chipsoft 
Electronisch Zorg Informatie Systeem’ (CS-EZIS), the computerized 
medical record system of the Maxima Medical Center. The database thus 
contained data regarding 24-hour urinary creatinine, serum creatinine, 
HbA1c, weight, length, age, and sex of each of these patients. In addition, 
BMI and BSA (BSA (m2) = 0.20247 × height (m)0.725 × weight (kg)0.425) 
[15] were calculated and added to the database. The patients were  divided 
into 3 groups based on their BMI according to the WHO classification: a 
normal group (BMI 18–24.9 kg/m2), an overweight group (BMI 25–29.9 
kg/m2), and an obese group ((BMI ≥ 30 kg/m2) (www.who.int/mediacentre/
factsheets/fs311/en/index.html; accessed May 25, 2011). 13 patients with a 
Crcl of more than 250 ml/min and 2 patients who were younger than 18 
years old were excluded, as the eGFR prediction equations are not vali-
dated in this patient group. In cases in which more than 1 24-hour urine 
 sample was performed (n = 236) in the indicated period, the most recent 
sample was used. Ultimately, the database contained complete data for 
844 patients. The population is a mixture of type 1 diabetes mellitus 
(T1DM) and type 2 diabetes mellitus (T2DM) patients. The exact num-
bers of each type are unknown. Permission from the Medical Ethics Com-
mittee was not required, as our data only included anonymized patient 
characteristics and laboratory data. 
Renal Function Measurement
The enzymatic Roche Modular P method, validated by isotope dilution 
mass spectrometry (IDMS), was used to measure serum and urinary cre-
atinine. The 4-variable MDRD and the CKD-EPI were used to estimate 
GFR (for formulae, see table 1). Crcl was estimated by using the CG 
equation. In this study, measured Crcl was used as a reference value for 
renal function. This value was based on a 24-hour urine collection, and 
calculated using the formula U×V/P (table 1) to calculate the 24-hour 
 creatinine clearance rate. In order to make a better comparison between 
Creatinine clearance:
U (creatinine concentration in urine; +mol/ml) × V (urine volume; ml/min) / P (creatinine concentration in plasma in (+mol/ml)
Cockroft-Gault equation (ml/min):
1.23 × (140 – age)/serum creatinine) × weight (× 0.85 for women)
4-variable Modification of Diet in Renal Disease (MDRD) equation (ml/min/1.73 m2):
175 × (serum creatinine (+mol/l)/88.4)–1.154 × age (years)–0.203 (× 0.742 for women)
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (ml/min/1.73 m2):
141 × min (serum creatinine (mg/dl)/k,1)a × max (serum creatinine (mg/dl)/k,1)–1.209 × 0.993age (× 1.018 for women)
k = 0.7 for females and 0.9 for males; a = –0.329 for females and –0.411 for males; min = minimum of SCr/k or 1;  
max = maximum of SCr/k or 1.
Table 1. Prediction 
equations
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MDRD, the MDRD-BSA, the CKD-EPI, the CKD-EPI-BSA, and the 
CG. Krippendorff’s coefficient was used as an aggregate measure for 
method concordance. A Krippendorff’s coefficient of 1 shows perfect 
concordance between 2 methods and a Krippendorff’s coefficient of –1 
shows perfect discordance [16]. Bias was defined as the mean difference 
between the renal function prediction equations and Crcl, whereas preci-
sion was defined as the SD of this difference. Accuracy (a combination of 
bias and precision), and the percentage of patients who had an estimated 
kidney function within 30% and 50% limits of the Crcl, were calculated. 
Results
Population Characteristics and Design
The patient characteristics of this study are presented in table 
2. The mean (SD) Crcl of the overall study population was 
112 (45) ml/min. The mean renal function of the overall po-
pulation estimated with the MDRD, MDRD-BSA, CKD-
EPI, CKD-EPI-BSA, and CG was 76 (25) ml/min/1.73 m2, 87 
the estimations of the MDRD/CKD-EPI on the one hand versus the CG/
Crcl on the other hand, the results of the MDRD and CKD-EPI were 
 recalculated for the individual BSA (using the DuBois formula [15] 
as mentioned above) of each patient (designated as MDRD-BSA and 
CKD-EPI-BSA, respectively).
Statistical Analysis
Data analysis was performed using SPSS version 16.0 (SPPS Inc., Chi-
cago, IL, USA). Demographic data were stratified according to BMI 
 categories, and presented as median (interquartile range, IQR) or mean 
(standard deviation, SD), depending on whether data were skewed or 
not. The Student’s t-test, the chi-square test, or ANOVA were used to 
compare demographic characteristics and the values of the renal function 
prediction equations between the BMI categories. The accuracy of the 
renal function prediction formulae for the different BMI categories was 
compared using the McNemar test. The performance of the GFR predic-
tion equations, the GFR prediction equations corrected for BSA, and the 
CG were compared by calculating correlation, Krippendorf’s coefficient 
[16], bias, precision (the SD of the bias), and accuracy for each BMI cate-
gory. Spearman’s coefficient of correlation was calculated for each BMI 
category to determine the correlation between Crcl and the results of the 
Normal




BMI ≥ 30 kg/m2
Patients, n (%) 243 (29.0) 295 (35.0) 306 (36)
Age, medium, years (IQR)  65 (48–73)  63 (54–71)  63 (56–72)
Male sex, %  57  65  44
Weight, kg (IQR)  70 (63–76)  80 (74–90)  97 (89–109)
BMI, kg/m2 (IQR)  23 (22–24)  27 (26–29)  33 (31–37)
HbA1c, % (IQR)   6.7 (6.0–7.4)   6.6 (5.9–7.4)   6.9 (6.1–7.6)
Serum creatinine, +mol/l (IQR)  78 (66–93)  83 (71–103)  78 (66–98)
BSA, mean, m2 (SD)   1.8 (0.2)   1.9 (0.2)   2.1 (0.2)
Creatinine clearance, mean, ml/min (SD) 104 (41) 109 (42) 121 (51)
CG, mean, ml/min (SD)  85 (34)  91 (34) 116 (49)
CKD-EPI, mean, ml/min/1.73 m2 (SD)  82 (24)  77 (24)  77 (23)
CKD-EPI-BSA, mean, ml/min (SD)  87 (28)  87 (29)  94 (31)
MDRD, mean, ml/min/1.73 m2 (SD)  82 (28)  77 (29)  79 (30)
MDRD-BSA, mean, ml/min (SD)  85 (29)  84 (29)  92 (34)
BMI = Body mass index; IQR = interquartile range; BSA = body surface area; CG = Cockcroft-Gault  equation;  
CKD-EPI = chronic kidney disease epidemiology collaboration equation; CKD-EPI-BSA = CKD-EPI corrected for body 
surface area; MDRD = Modification of Diet in Renal  Disease (4-variable MDRD used in this study);  
MDRD-BSA = MDRD corrected for body surface area.
Table 2. Patient 
characteristics
Table 3. Correlation and Krippendorff’s coefficient (KC) for CG and eGFR values per BMI category








BMI < 25 kg/m2 0.82a (0.71) 0.75a (0.58) 0.80a (0.66) 0.76a (0.55) 0.82a (0.68)
BMI 25–29.9 kg/m2 0.81a (0.71) 0.78a (0.52) 0.82a (0.62) 0.79a (0.47) 0.82a (0.65)
BMI ≥ 30 kg/ m2 0.75a (0.75) 0.72a (0.42) 0.77a (0.58) 0.72a (0.33) 0.78a (0.57)
aSpearman’s correlation coefficient.
KC = Krippendorff’s coefficient; BMI = body mass index; BSA = body surface area; CG = Cockcroft-Gault equation;  
eGFR = estimated glomerular filtration rate; CKD-EPI = chronic kidney disease epidemiology collaboration equation;  
CKD-EPI-BSA = CKD-EPI corrected for body surface area; MDRD = Modification of Diet in Renal Disease (4-variable MDRD used in this study); 
MDRD-BSA = MDRD corrected for body surface area.
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Correlation and Krippendorff’s Coefficient
Both GFR estimates, also after a correction for BSA, and the 
CG result were correlated with the Crcl value of each BMI cat-
egory (table 3). Overall, the Spearman’s correlation coefficient 
was 0.73 for the MDRD, 0.80 for the MDRD-BSA, 0.74 for the 
CKD-EPI, 0.81 for the CKD-EPI-BSA, and 0.78 for the CG 
equation. If no correction for BSA takes place, the correlation 
between the CG and the Crcl proves to be superior to the GFR 
prediction equations in all BMI categories, except for the 
MDRD equation in the normal weight category (as might be 
expected). When GFR formulae are corrected for BSA, the 
correlation between the CKD-EPI-BSA and MDRD-BSA re-
sults is stronger than between the CG result and Crcl in all 
BMI categories. Because correlation alone is insufficient to 
prove the concordance among methods, the Krippendorff’s co-
efficient was calculated (table 3). The best concordance was 
found between the CG result and Crcl within all BMI catego-
ries. The CKD-EPI result had the worst concordance with Crcl 
in all BMI categories, even after correction for BSA. 
(31) ml/min, 78 (24) ml/min/1.73 m2, 90 (30) ml/min, and 99 
(42) ml/min, respectively. The total study population was 
equally divided between the BMI categories, and included 
subjects across a wide range of ages (20–92 years), with BMI 
scores ranging between 15 and 58 kg/m2. The Crcl values 
ranged between 11 and 250 ml/min. Although nonsignificant, 
there were considerable differences in sex distribution be-
tween the BMI categories. No significant differences in age 
and HbA1c were observed between the BMI categories. After 
calculating the results of the GFR prediction equations and 
the CG equation for each BMI category, only the MDRD re-
sult was significantly different between the normal group 
(BMI < 25 kg/m2) and the overweight group (BMI 25–29.9 kg/m2) 
(p < 0.04). Between the normal and obese group, significant 
differences were found for the Crcl value (p < 0.01), MDRD-
BSA (p < 0.01), and CG result (p < 0.001). However, when 
the GFR prediction equations were not corrected for BSA, no 
significant differences were found (MDRD equation: p < 0.95, 
CKD-EPI equation: p < 0.97). 
Fig. 1. Mean bias per BMI category. Mean 
bias (ml/min/1.73 m2) of each renal function 
prediction equation stratified according to BMI 
category (kg/m2). Bias is defined as mean dif-
ference between estimate and creatinine clear-
ance. MDRD-B = MDRD corrected for body 
surface area.
Table 4. Precision and accuracy for eGFR prediction equations and CG per BMI category 








BMI < 25 kg/m2 
(normal weight)
precisiona 25.5 28.3 25.9 28.0 24.9
accuracyb 30% 70.4 63.3 72.0 67.1 67.1
accuracy 50% 95.1 94.7 96.3 95.1 95.1
BMI 25–29.9 kg/m2 
(overweight)
precision 24.9 28.4 25.2 26.9 24.3
accuracy 30% 76.9 45.8 67.5 51.9 51.9
accuracy 50% 96.9 92.5 97.3 94.2 94.2
BMI ≥ 30 kg/m2 
(obese)
precision 38.0 36.2 34.8 37.7 33.0
accuracy 30% 76.8 34.0 58.5 37.3 37.3
accuracy 50% 90.5 82.0 94.4 85.3 85.3
aDefined as 1 SD of the bias (ml/min/1.73 m2).
bDefined as percentage of GFR estimation within ± 30 and ± 50% range of respective creatinine clearance measurements.
BMI = Body mass index; BSA = body surface area; CG = Cockcroft-Gault equation; eGFR = estimated glomerular filtration rate;  
CKD-EPI = chronic kidney disease epidemiology collaboration equation; CKD-EPI-BSA = CKD-EPI corrected for body surface area;  
MDRD = Modification of Diet in Renal Disease (4-variable MDRD used in this study); MDRD-BSA = MDRD corrected for body surface area.
%0,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 %0,±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to an increase in GFR of each single nephron since the 
number of nephrons will not increase with increasing body fat 
[23]. Ultimately, nephrons will function near to or on maxi-
mum capacity, i.e. hyperfiltration. Correcting GFR for BSA 
obscures this problem, as was shown in a cohort of 81 obese 
patients (BMI 41 ± 9 kg/m2) with a mean GFR of 101 ± 
24 ml/min (measured by 51Cr-EDTA) and a mean indexed 
GFR of 76 ± 16 ml/min/1.73 m2 [24]. When the absolute GFR 
or the indexed GFR were used as a reference, the MDRD 
 formula underestimated (mean difference –11 ± 20 ml/min) 
and overestimated (mean difference 14 ± 18 ml/min/1.73 m2) 
the measured GFR, respectively. The observed underestima-
tion of the GFR using the MDRD can be expected based on 
pre vious literature; however, the overestimation when using 
an indexed GFR is remarkable and suggests that back-correc-
tion for BSA is needed [24].
Although overweight and obesity have almost reached epi-
demic proportions nowadays, the Caring for Australians with 
Renal Impairment (CARI) guidelines are the only guidelines 
that mention the influence of weight on the GFR prediction 
equations [25]. These guidelines are also the only ones warning 
against the unreliable prediction results of the MDRD equa-
tion in an overweight and obese population [25]. The influence 
of weight on renal function equations should however, be con-
sidered, especially since many laboratories have started to use 
automated reporting of MDRD estimates. More importantly, 
clinical decisions are based on these renal function estimates. 
The observation in our study, that the CG equation had the 
least bias in overweight and obese subjects, is supported by 
previous publications [17, 18]. In a population of newly diag-
nosed T2DM patients with a mean isotopic GFR of 115 ml/
min/1.73 m2, the CG equation had the most pronounced bias 
in lean subjects (mean –20.6 ml/min/1.73 m2, confidence inter-
val (CI) –23.9 to –17.3), and a bias that diminished with 
 increasing body weight (–5.6 ml/min/1.73 m2 in an obese pop-
ulation). Contrarily, the bias of the MDRD increased (from 
–21.3 ml/min/1.73 m2 in the normal weight group to –28.9 ml/
min/1.73 m2 in the obese group), while accuracy decreased 
[19]. The fact that we found more pronounced results com-
pared to the study by Chudleigh et al. [19] might be due to the 
use of Crcl values instead of 51Cr-EDTA values as a reference 
for renal function. Verhave et al. [17] studied the performance 
of the CG and MDRD equations in a diverse cohort of out-
patients with serum creatinine levels of less than 1.5 mg/dl 
(< 133 +mol/l). In their study, a rather similar trend for the CG 
was found, except that in the obese population an overestima-
tion of +10.1 ml/min was found. This is in contrast to our study 
in which we found a small underestimation. Also in contrast 
to our findings, the investigators found that the MDRD equa-
tion underestimated the GFR to a certain extent (approxi-
mately –12.4 ml/min/1.73 m2), irrespective of BMI [17]. It is 
possible that their results slightly differ from our results be-
cause of differences in creatinine measurement. In our study, 
creatinine was calibrated to IDMS. 
Bias and Precision
All prediction equations had a negative bias in the various 
BMI categories. The bias varied widely, as can be seen in fig-
ure 1. The higher the BMI, the greater the mean bias for both 
the MDRD and the CKD-EPI equation (fig. 1). When the 
MDRD and the CKD-EPI were corrected for BSA, the re-
sults were similar. However, the mean bias for these 2 equa-
tions did not increase as much in the higher BMI categories 
(fig. 1). For the CG equation, a decreasing trend in bias was 
observed with increasing BMI, from –18.7 ml/min in BMI 
< 25 kg/m2 to –4.0 ml/min in BMI ≥ 30 kg/m2 (p < 0.001). No 
significant differences in performance were found between 
the CKD-EPI and the MDRD equations in the normal weight 
and overweight group (p = 0.88 and p = 0.50, respectively). In 
the obese patient group, the MDRD performed significantly 
better than the CKD-EPI (p = 0.01). The precision of all these 
formulas varied widely in all BMI categories (table 4).
Accuracy
In table 4, the accuracy of the various renal function estimates 
is presented for each BMI category. The CG had the best ac-
curacy (> 70.4%) in all BMI categories. The CKD-EPI equa-
tion had a better accuracy than the MDRD equation in all 
BMI categories (when a dispersion of 30% was tolerated), al-
though the difference in accuracy was only significant in the 
overweight group (< 0.01); accuracy decreased with increasing 
BMI. However, when the GFR prediction equations were 
corrected for BSA, the MDRD-BSA performed significantly 
better in all BMI categories than the CKD-EPI-BSA (p < 0.01), 
and the higher the BMI, the lower the accuracy.
Discussion
This study shows that the CG is a better predictor of renal 
function than the MDRD and the CKD-EPI in diabetic pa-
tients, especially when patients are overweight or obese, at 
least when Crcl is used as a reference value. The MDRD and 
CKD-EPI equations provided less accurate results for over-
weight and obese patients. Even though the renal function in 
the studied population was good (mean Crcl 112 ml/min), the 
recently developed CKD-EPI did not perform significantly 
better than the MDRD. When the MDRD and CKD-EPI 
were corrected for BSA, bias and accuracy improved. Even 
so, the CG outperformed the GFR prediction equations in the 
overweight and obese patient group. 
The limitations of creatinine-based prediction equations in 
overweight and obese populations have been discussed in the 
literature before [17–22]. There is still an ongoing debate 
about renal function prediction equations in these popula-
tions. A condition frequently encountered in obese and dia-
betic patients that should be taken into account in this debate 
is renal hyperfiltration. The suggested underlying mechanism 
is that progressive obesity alters renal hemodynamics, leading 
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ance methods that are reserved for research purposes. Unfor-
tunately, details concerning duration of DM, blood glucose 
lowering treatment, and the presence of albuminuria are not 
available for this population due to the method of data collec-
tion. The inclusion of such data would have allowed the analy-
sis to be more complete.
An important strength of our study is that creatinine clear-
ances in our cohort ranged from 10.7 to 249.5 ml/min. In addi-
tion, the majority of our subjects had normal or mildly de-
creased renal function. The performances of the CG, MDRD, 
and CKD-EPI equations could therefore be assessed over a 
wide range of renal functions. Furthermore, recent studies 
have emphasized the importance of careful calibration of 
serum creatinine measurements in order to further improve 
the reliability of the GFR estimation formulae [26]. In this 
study, IDMS-calibrated serum creatinine measurements were 
used, so misclassification of renal function due to less reliable 
creatinine testing is unlikely.
Conclusion
In this study, performed among diabetic patients in various 
weight categories, the CG was the best predictor of renal 
function compared to the 4-variable MDRD and CKD-EPI 
when used in an overweight or obese population. The recently 
developed CKD-EPI equation has no additional value over 
the existing prediction equations. When the existing predic-
tion equations are used in clinical practice, their disadvan-
tages should be kept in mind when making decisions based on 
the results of these equations. 
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The influence of weight on the CKD-EPI has not yet been 
evaluated in a cohort of diabetic subjects. In a recently pub-
lished study performed among potential kidney donors (mean 
Crcl 78.2 ml/min/1.73 m2), the researchers found that the 
CKD-EPI and the MDRD equations were not influenced by 
BMI, contrary to the CG [20].
Many of the above mentioned studies, comparing the per-
formance of the CG and the MDRD, use an indexed CG 
equation (often the standard BSA of 1.73 m2). In our opinion, 
this is incorrect. Since weight is one of the clinical variables 
included in the CG equation, a correction for BSA will result 
in a double correction for weight. This double correction may 
well have influenced the performance of the equation in 
these studies. Moreover, a correction to a standard BSA of 
1.73 m2 may result in a worse performance of the MDRD and 
CKD-EPI equations. In patients with a normal BMI, the im-
pact of a correction to a standard BSA of 1.73 m2 is rather 
small, since 1.73 m2 is approximately the BSA of a non-over-
weight person. However, such a correction will lead to con-
siderable underestimation of renal function in obese patients, 
since a lot of obese people have a BSA which grossly exceeds 
1.73 m2. When we corrected the values in our study to a 
standard BSA of 1.73 m2, the MDRD and CKD-EPI equa-
tions did indeed perform worse. But when we corrected the 
data to the actual BSA of participants, the performance of 
both the MDRD equation and the CKD-EPI equation im-
proved considerably. Another reason why the MDRD equa-
tion in our study performed worse than the other equations 
might be that the average renal function in the study popu-
lation was good and the MDRD equation has only been vali-
dated in a population with impaired renal function (MDRD 
< 60 ml/min/1.73 m2). 
Finally, Crcl is not a true reflection of GFR. Still, Crcl is a 
common way to measure renal function in daily practice; con-
trarily to various isotopic clearance techniques or other clear-
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